News

In biopharmaceutical manufacturing, the development of an expression system that stably produces high levels of desired recombinant protein can be a time consuming and resource-intensive process ...
Lack of pathogenicity and other advantages over Escherichia coli make Bacillus subtilis an attractive host expression system, says GenScript, especially if secretory capacity is enhanced.